GNPX
Genprex, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.50
+2.19%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-76.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Apr 15, 2026 | LONGNECKER BRENT M · director | Sale | 10 | $1.23 |
| Apr 15, 2026 | LONGNECKER BRENT M · director | Sale | 8 | $1.23 |
| Feb 27, 2026 | Berger Mark Stanley · officer: Chief Medical Officer | F-InKind | 7,168 | $2.00 |
| Feb 27, 2026 | Confer Ryan M. · director, officer: President, CEO and CFO | F-InKind | 9,330 | $2.00 |
| Dec 23, 2025 | Berger Mark Stanley · officer: Chief Medical Officer | A-Award | 28,500 | $0.00 |
| Dec 23, 2025 | Moreno Toscano Jose Antonio · director | A-Award | 9,000 | $0.00 |
| Dec 23, 2025 | LONGNECKER BRENT M · director | A-Award | 9,000 | $0.00 |
| Dec 23, 2025 | Wilson William R Jr. · director | A-Award | 9,000 | $0.00 |
| Dec 23, 2025 | Confer Ryan M. · director, officer: President, CEO and CFO | A-Award | 45,000 | $0.00 |
| Jul 1, 2025 | Berger Mark Stanley · officer: Chief Medical Officer | F-InKind | 4,500 | $0.23 |
| Jul 1, 2025 | Confer Ryan M. · director, officer: President, CEO and CFO | F-InKind | 5,775 | $0.23 |
| Feb 19, 2025 | Confer Ryan M. · director, officer: President, CEO and CFO | F-InKind | 395 | $0.41 |
| Feb 19, 2025 | Berger Mark Stanley · officer: Chief Medical Officer | F-InKind | 585 | $0.41 |
| Dec 6, 2024 | Berger Mark Stanley · officer: Chief Medical Officer | A-Award | 18,250 | $0.00 |
| Dec 6, 2024 | Moreno Toscano Jose Antonio · director | A-Award | 4,750 | $0.00 |
| Dec 6, 2024 | Wilson William R Jr. · director | A-Award | 4,750 | $0.00 |
| Dec 6, 2024 | LONGNECKER BRENT M · director | A-Award | 4,750 | $0.00 |
| Dec 6, 2024 | Confer Ryan M. · director, officer: President, CEO and CFO | A-Award | 29,375 | $0.00 |
| Feb 21, 2024 | Confer Ryan M. · officer: Chief Financial Officer | F-InKind | 1,126 | $4.40 |
| Feb 21, 2024 | Varner John Rodney · director, officer: Chairman, President and CEO | F-InKind | 2,642 | $4.40 |
| Feb 21, 2024 | Berger Mark Stanley · officer: Chief Medical Officer | F-InKind | 1,319 | $4.40 |
| Jun 29, 2023 | LONGNECKER BRENT M · director | A-Award | 123,795 | $0.00 |
| Jun 29, 2023 | Wilson William R Jr. · director | A-Award | 123,795 | $0.00 |
| Jun 29, 2023 | Moreno Toscano Jose Antonio · director | A-Award | 123,795 | $0.00 |
| Apr 24, 2023 | VACZY CATHERINE M · officer: EVP GC Chief Strategy Officer | Purchase | 20,000 | $1.07 |
| Apr 24, 2023 | Varner John Rodney · director, officer: Chairman, President and CEO | Purchase | 19,000 | $1.05 |
| Feb 22, 2023 | Varner John Rodney · director, officer: President & CEO | A-Award | 625,000 | $0.00 |
| Feb 22, 2023 | Confer Ryan M. · officer: Chief Financial Officer | A-Award | 245,000 | $0.00 |
| Feb 22, 2023 | Kumar Hermant · officer: Chief Mfgr & Tech Officer | A-Award | 200,000 | $0.00 |
| Feb 22, 2023 | Berger Mark Stanley · officer: Chief Medical Officer | A-Award | 245,000 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 11Increased 2Reduced 3Sold out 27
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | New Position | 33,372 | May 15, 2026 |
| MANCHESTER FINANCIAL INC | New Position | 20,000 | Apr 23, 2026 |
| MAYFLOWER FINANCIAL ADVISORS, LLC | New Position | 20,000 | Apr 23, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 5,950 | May 15, 2026 |
| FNY INVESTMENT ADVISERS, LLC | New Position | 5,000 | Apr 15, 2026 |
| Cygnus Capital Advisors, LLC | New Position | 2,195 | May 13, 2026 |
| JONES FINANCIAL COMPANIES LLLP | Increased | 2,105 | May 15, 2026 |
| CITIGROUP INC | Increased | 2,039 | May 11, 2026 |
| SOUND INCOME STRATEGIES, LLC | New Position | 1,000 | Apr 27, 2026 |
| CHEVIOT VALUE MANAGEMENT, LLC | Unchanged | 1,000 | May 12, 2026 |
| ADVISOR GROUP HOLDINGS, INC. | Unchanged | 232 | May 15, 2026 |
| BERNARD WEALTH MANAGEMENT CORP. | New Position | 200 | May 15, 2026 |
| BLACKROCK, INC. | Unchanged | 188 | May 13, 2026 |
| HARBOUR INVESTMENTS, INC. | New Position | 120 | May 15, 2026 |
| SBI SECURITIES CO., LTD. | Unchanged | 48 | Apr 28, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 15, 2026